According to Theravance Biopharma 's latest financial reports the company's total debt is $49.15 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $49.15 M | -5.75% |
2022-12-31 | $52.16 M | -92.21% |
2021-12-31 | $0.66 B | -1% |
2020-12-31 | $0.67 B | 32.46% |
2019-12-31 | $0.51 B | 12.36% |
2018-12-31 | $0.45 B | 103.07% |
2017-12-31 | $0.22 B | 0.48% |
2016-12-31 | $0.22 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Corcept Therapeutics
CORT | $0.15 M | -99.69% | ๐บ๐ธ USA |
Collegium Pharmaceutical
COLL | $0.67 B | 1,271.64% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $3.55 M | -92.76% | ๐บ๐ธ USA |
Catalent CTLT | $5.01 B | 10,099.56% | ๐บ๐ธ USA |